The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Zenas Biopharma Inc shares valued at $166,750 were purchased by MOULDER LEON O JR on Feb 18 ’25. At $6.67 per share, MOULDER LEON O JR acquired 25,000 shares. The insider’s holdings grew to 266,155 shares worth approximately $3.22 million following the completion of this transaction.
Also, Xiao Ting purchased 10,000 shares, netting a total of over 77,600 in proceeds. Following the buying of shares at $7.76 each, the insider now holds 47,000 shares.
Before that, MOULDER LEON O JR had added 45,000 shares to its account. In a trade valued at $449,100, the Chief Executive Officer bought Zenas Biopharma Inc shares for $9.98 each. Upon closing the transaction, the insider’s holdings increased to 45,000 shares, worth approximately $2.92 million.
As published in their initiating research note from Wedbush on March 20, 2025, Zenas Biopharma Inc [ZBIO] has been an Outperform and the price target has been revised to $35. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of December 16, 2024, H.C. Wainwright has initiated its “Buy” rating for ZBIO. Earlier on November 05, 2024, Rodman & Renshaw initiated its rating. Their recommendation was “a Buy” for ZBIO stock.
Analyzing ZBIO Stock Performance
During the last five days, there has been a surge of approximately 26.81%. Over the course of the year, Zenas Biopharma Inc shares have jumped approximately 47.86%.
Support And Resistance Levels for Zenas Biopharma Inc (ZBIO)
According to the 24-hour chart, there is a support level at 11.67, which, if violated, would cause prices to drop to 11.24. In the upper region, resistance lies at 12.52. The next price resistance is at 12.94. RSI (Relative Strength Index) is 62.39 on the 14-day chart, showing neutral technical sentiment.
